XML 35 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Unaudited Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 28, 2012
Mar. 30, 2012
Assets, Current [Abstract]    
Cash and cash equivalents $ 122,351 $ 163,152
Accounts receivable, net of allowance for doubtful accounts of $3,647 and $3,410as of September 28, 2012 and March 30, 2012, respectively 194,255 189,542
Inventories 165,629 147,198
Prepaid expenses 6,962 4,936
Other current assets 45,762 39,250
Assets held for sale 281,163 [1] 277,378 [1]
Total current assets 816,122 821,456
Property and equipment, net of accumulated depreciation of $145,024 and $134,235 as of September 28, 2012 and March 30, 2012, respectively 84,008 80,151
Other Assets, Noncurrent [Abstract]    
Goodwill 142,473 109,457
Intangibles, net of accumulated amortization of $18,168 and $14,037 as of September 28, 2012 and March 30, 2012, respectively 52,802 33,546
Other assets 116,564 111,360
Total assets 1,211,969 [1] 1,155,970 [1]
Liabilities, Current [Abstract]    
Accounts payable 132,071 118,719
Accrued expenses 36,096 37,436
Other current liabilities 12,635 8,015
Liabilities held for sale 47,186 [1] 37,640 [1]
Total current liabilities 227,988 201,810
Revolving line of credit and long-term debt, excluding current portion 459,845 454,916
Other noncurrent liabilities 112,937 108,433
Total liabilities 800,770 [1] 765,159
Commitments and contingencies (Note 13)      
Equity [Abstract]    
Preferred stock, $0.01 par value; 1,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, $0.01 par value; 150,000,000 shares authorized, 50,313,887 and 50,312,323 shares issued and outstanding as of September 28, 2012 and March 30, 2012, respectively 494 495
Retained earnings 407,106 386,633
Total PSS World Medical, Inc. shareholders' equity 407,600 387,128
Noncontrolling interest 3,599 3,683
Total equity 411,199 390,811
Total liabilities and equity $ 1,211,969 $ 1,155,970
[1] See Footnote 4, Variable Interest Entity, for discussion of the assets and liabilities related to the Company’s consolidated variable interest entities. See Footnote 3, Discontinued Operations, for discussion of assets and liabilities held for sale.